Prostaglandins and premenstrual syndrome.
We examined plasma PGF2 alpha, PGE, PGE2, TXB2 and 6-keto-PGF1 alpha at intervals throughout 3 menstrual cycles in 20 patients with PMS. Similar measurements throughout 1 menstrual cycle were made in 12 age-matched control women. The plasma concentration of PGF2 alpha in the late luteal phase was significantly lower in patients with PMS compared with that in the control subjects. The plasma concentrations of PGE in the middle follicular phase and middle luteal phase, PGE2 alpha in the middle follicular phase and TXB2 in the middle and late luteal phase were significantly higher in 20 patients compared with the values in the controls. A disturbance of PG metabolism may contribute to the etiology of PMS.
Koshikawa
N
N
Department of Psychiatry, National Defense Medical College, Saitama, Japan.
Tatsunuma
T
T
Furuya
K
K
Seki
K
K
D000293:Adolescent; D000328:Adult; D015237:Dinoprost / Q000097:blood; D005260:Female; D005498:Follicular Phase; D006801:Humans; D008183:Luteal Phase; D011293:Premenstrual Syndrome / Q000097:blood* / Q000209:etiology; D011453:Prostaglandins / Q000097:blood*; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires
D011453:Prostaglandins; D015237:Dinoprost